Login / Signup
Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients.
Yoshifumi Amari
Satoshi Morimoto
Takashi Teranishi
Yu Motoike
Takatomi Yurugi
Yasuo Oyama
Fumitaka Nakajima
Hitoshi Kobayashi
Published in:
Clinical nephrology (2024)
This study confirmed that patients undergoing hemodialysis were proven to have acquired sufficient antibody titers after the vaccination.
Keyphrases
</>
sars cov
patients undergoing
chronic kidney disease
end stage renal disease
peritoneal dialysis
respiratory syndrome coronavirus